Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2006-10-26
pubmed:abstractText
Endothelial dysfunction is a characteristic finding in both patients with type 1 diabetes and in regular smokers and is an important precursor to atherosclerosis. The urate molecule has antioxidant properties, which could influence endothelial function. The impact of acutely raising uric acid concentrations on endothelial function was studied in eight men with type 1 diabetes, eight healthy regular smokers, and eight age-matched healthy control subjects in a randomized, four-way, double-blind, placebo-controlled study. Subjects received 1,000 mg uric acid i.v. in vehicle, 1,000 mg vitamin C as a control antioxidant, vehicle alone, or 0.9% saline on separate occasions over 1 h. Forearm blood flow responses to intrabrachial acetylcholine and sodium nitroprusside were assessed using venous occlusion plethysmography. Responses to acetylcholine, but not sodium nitroprusside, were impaired in patients with diabetes (P < 0.001) and in smokers (P < 0.005) compared with control subjects. Administration of uric acid and vitamin C selectively improved acetylcholine responses in patients with type 1 diabetes (P < 0.01) and in regular smokers (P < 0.05). Uric acid administration improved endothelial function in the forearm vascular bed of patients with type 1 diabetes and smokers, suggesting that high uric acid concentrations in vivo might serve a protective role in these and other conditions associated with increased cardiovascular risk.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0012-1797
pubmed:author
pubmed:issnType
Print
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3127-32
pubmed:dateRevised
2007-2-15
pubmed:meshHeading
pubmed-meshheading:17065352-Acetylcholine, pubmed-meshheading:17065352-Adult, pubmed-meshheading:17065352-Antioxidants, pubmed-meshheading:17065352-Ascorbic Acid, pubmed-meshheading:17065352-Blood Flow Velocity, pubmed-meshheading:17065352-Blood Pressure, pubmed-meshheading:17065352-Body Mass Index, pubmed-meshheading:17065352-Cross-Over Studies, pubmed-meshheading:17065352-Diabetes Mellitus, Type 1, pubmed-meshheading:17065352-Double-Blind Method, pubmed-meshheading:17065352-Endothelium, Vascular, pubmed-meshheading:17065352-Forearm, pubmed-meshheading:17065352-Heart Rate, pubmed-meshheading:17065352-Humans, pubmed-meshheading:17065352-Male, pubmed-meshheading:17065352-Nitroprusside, pubmed-meshheading:17065352-Placebos, pubmed-meshheading:17065352-Reference Values, pubmed-meshheading:17065352-Smoking, pubmed-meshheading:17065352-Uric Acid
pubmed:year
2006
pubmed:articleTitle
Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers.
pubmed:affiliation
Clinical Pharmacology Unit, University of Edinburgh, The Queen's Medical Research Institute, 3rd Floor East, Room E3.22, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. s.waring@ed.ac.uk
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't